Table 2B.
Descriptive statistics for various parameters according to the mortality
| Parameters | Mortality | p value | ||
|---|---|---|---|---|
| No (n = 198) | Yes (n = 34) | |||
| 1 | Hb (M ± SD) | 9.34 ± 2.62 | 8.79 ± 2.88 | 0.261 |
| 2 | TLC (M ± SD) | 9408.54 ± 5259.56 | 13076.76 ± 6755.04 | <0.0001 |
| 3 | N (M ± SD) | 74.38 ± 11.44 | 81.09 ± 10.43 | 0.002 |
| 4 | Platelets (M ± SD) | 1.44 ± 0.98 | 0.95 ± 0.43 | 0.005 |
| 5 | T bilirubin (M ± SD) | 5.01 ± 6.03 | 12.22 ± 9.48 | <0.0001 |
| 6 | D bilirubin (M ± SD) | 3 ± 4.33 | 6.19 ± 5.15 | <0.0001 |
| 7 | AST (M ± SD) | 129.88 ± 553.41 | 236.76 ± 524.18 | 0.296 |
| 8 | ALT (M ± SD) | 74.75 ± 228.22 | 164.62 ± 411.28 | 0.066 |
| 9 | AST:ALT R (M ± SD) | 1.73 ± 0.75 | 1.96 ± 0.92 | 0.125 |
| 10 | ALP (M ± SD) | 349.55 ± 298.05 | 333.32 ± 195.27 | 0.76 |
| 11 | Protein (M ± SD) | 6.16 ± 0.81 | 6.04 ± 0.96 | 0.407 |
| 12 | Albumin (M ± SD) | 3.13 ± 0.57 | 2.93 ± 0.64 | 0.062 |
| 13 | PT (M ± SD) | 21.61 ± 6.05 | 38.56 ± 16.84 | <0.0001 |
| 14 | INR (M ± SD) | 1.63 ± 0.65 | 3.09 ± 1.43 | <0.0001 |
| 15 | Urea (M ± SD) | 40.57 ± 25.52 | 60.82 ± 45.68 | <0.0001 |
| 16 | Creatinine (M ± SD) | 1.15 ± 0.72 | 2.04 ± 1.6 | <0.0001 |
| 17 | Na (M ± SD) | 134.91 ± 7.22 | 133.59 ± 7.41 | 0.325 |
| 18 | K (M ± SD) | 4.11 ± 0.72 | 4.42 ± 1.25 | 0.047 |
| 19 | DF (M ± SD) | 39.91 ± 29.8 | 124.44 ± 78.74 | <0.0001 |
| 20 | MELD (M ± SD) | 16.96 ± 6.52 | 31 ± 8.93 | <0.0001 |
| 21 | CTP [no. (%)] A | 65 (32.8) | 2 (5.9) | <0.0001 |
| B | 84 (42.4) | 5 (14.7) | ||
| C | 49 (24.8) | 27 (79.4) | ||
M, mean; SD, standard deviation; HB, hemoglobin; INR, international normalized ratio; PT, prothrombin time; DF, discriminant function; MELD, model for end-stage liver disease; CTP, Child–Turcotte–Pugh; TLC, total leucocyte count; N, neutrophil; AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase; AST:ALT R, AST to ALT ratio
p values in boldface indicate statistical significance